Moreover, a randomized controlled trial reported that chemoradiotherapy followed by a PD-L1 inhibitor yielded prognostic benefits in patients with locally advanced non-small cell lung cancer [27]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.